Although we have demonstrated that WSB2 is highly expressed in HCC tissues and that high WSB2 expression is correlated with adverse clinical features, this phenomenon was mainly observed in the wild-type TP53 group. Here, WSB2 is linked to hepatocellular carcinoma.